JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200174200 on February 20, 2002

J. Biol. Chem., Vol. 277, Issue 19, 16489-16497, May 10, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/19/16489    most recent
M200174200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Myung, K. S.
Right arrow Articles by Donelson, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Myung, K. S.
Right arrow Articles by Donelson, J. E.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Comparison of the Post-transcriptional Regulation of the mRNAs for the Surface Proteins PSA (GP46) and MSP (GP63) of Leishmania chagasi*

Karen S. MyungDagger §, Jeffrey K. BeethamDagger , Mary E. Wilson§||**Dagger Dagger , and John E. DonelsonDagger §§§

From the Departments of Dagger  Biochemistry, || Microbiology, and ** Internal Medicine and the § Medical Scientist Training Program, University of Iowa and the Dagger Dagger  Veterans Affairs Medical Center, Iowa City, Iowa 52242

Received for publication, January 8, 2002, and in revised form, February 1, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

MSP (GP63) and PSA (GP46) are abundant 63- and 46-kDa glycolipid-anchored proteins on the surface of the promastigote form of most Leishmania species. MSP is a zinc metalloprotease that confers resistance to host complement-mediated lysis. PSA contains internal repeats of 24 amino acids, and its function is unknown. The steady state levels of mRNAs for both glycoproteins are regulated post-transcriptionally, resulting in about a 30-fold increase as Leishmania chagasi promastigotes grow in vitro from logarithmic phase to stationary phase. Previous studies showed the 3'-untranslated regions (3'-UTRs) of these mRNAs are essential for this post-transcriptional regulation. These two 3'-UTRs of 1.0 and 1.3 kilobases were cloned immediately downstream of a beta -galactosidase reporter gene in a plasmid, and segments were systematically deleted to examine which portions of the 3'-UTRs contribute to the post-transcriptional regulation. The 92-nucleotide segment of greatest similarity between the two 3'-UTRs was deleted without loss of regulation, but the segments flanking this similarity region have positive regulatory elements essential for the regulation. We propose that similar, but non-identical, molecular mechanisms regulate the parallel expression of these two L. chagasi mRNAs despite their lack of sequence identity. These post-transcriptional mechanisms resemble the mechanism recently suggested for the regulation of mRNAs encoding the dipeptide (EP) and pentapeptide (GPEET) repeat proteins in Trypanosoma brucei that involves interactions between positive and negative regulatory elements in the 3'-UTR.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Protozoan parasites of the genus Leishmania cause a diverse group of diseases collectively called leishmaniasis that range in severity from spontaneously healing cutaneous ulcers to potentially fatal visceral disease. During their life cycle the Leishmania sp. exist as two developmental stages, i.e. as extracellular promastigotes in the gut of the sandfly vector and as intracellular amastigotes in the phagolysosome of mammalian macrophages. Glycoproteins on the surface of the organism play important roles in its survival in both of these environments. The two best characterized Leishmania surface glycoproteins are the major surface protease (MSP,1 also called GP63 for 63-kDa glycoprotein) and the parasite surface antigen (PSA, also named GP46 for 46-kDa glycoprotein). Although these proteins have historically been called GP63 and GP46, the Nomenclature Working Group for Protozoan Parasites has recommended that protozoan proteins be assigned 3-6-letter names (1), so we will use the nomenclature of MSP and PSA here. Immunization with recombinant versions of either of these proteins or their genes via DNA vaccines provides experimental animals with partial protection against Leishmania challenge (2-6).

Leishmania MSP is a family of closely related zinc metalloproteases that have been found in different reports to (i) confer resistance of promastigotes to complement-mediated lysis (7), (ii) promote attachment to and internalization of promastigotes by host macrophages (8), and (iii) facilitate the intracellular survival of amastigotes in phagolysosomes of host macrophages (9). When virulent promastigotes develop during growth in culture from the less infectious logarithmic phase to the highly infectious stationary form, an 11-30-fold increase in MSP expression occurs (10-12). In Leishmania chagasi, which causes visceral leishmaniasis in Latin America, MSP is encoded by more than 18 genes (MSPs) that fall into three classes on the basis of (i) the stage at which they are expressed in the life cycle and (ii) unique sequences in their 3'-untranslated regions (UTRs) and intergenic regions (IRs) (13). In virulent promastigotes, 3.0-kb MSPS RNAs are expressed in stationary (S) phase but not logarithmic phase of growth, whereas 2.7-kb MSPL RNAs are expressed during logarithmic (L) but not stationary phase. MSPC RNAs of 2.6 and 3.1 kb are constitutively (C) expressed at low levels in both logarithmic and stationary phase (14).

PSA is another family of closely related proteins that have been detected in all Leishmania species examined except for members of the Leishmania braziliensis complex (15-18). All reported nascent PSA sequences contain hydrophobic amino- and carboxyl termini that are likely cleaved during translocation of the protein across the endoplasmic reticulum and its linkage to a glycolipid anchor. The function(s) of PSAs is not known, but they possess 3-13 internal leucine-rich repeats of 24 amino acids that have been shown in other proteins to participate in protein-protein interactions (19). The organization of the PSA genes (PSAs) has not been fully characterized in any Leishmania species, but in those that have been investigated the multiple non-identical PSAs occur in clusters (18-20). In L. chagasi promastigotes, expression of the 2.8-kb PSA mRNA parallels that of 3.0-kb MSPS mRNA during growth in vitro. The steady state levels of both RNA species increase more than 30-fold as the promastigotes develop from the less infectious, logarithmic form to the highly infectious, stationary form (20). Stationary promastigotes have approximately equal amounts of the PSA and MSP RNAs, which together constitute 2-3% of the total mRNA in the cell.

Leishmania and other trypanosomatids do not appear to have promoters for RNA polymerase II, which transcribes protein-encoding genes, even though transcription of these genes is sensitive to alpha -amanitin as it is in other eukaryotes (21). Instead, these genes are constitutively transcribed from large gene clusters, and the steady state levels of their mature mRNAs are regulated post-transcriptionally by mechanisms that often involve their 3'-UTR sequences (22-28). Because the abundance of the PSA and MSPS RNAs in L. chagasi promastigotes are regulated in parallel, we inspected their 3'-UTRs to see if their 1.0-kb (MSP) and 1.3-kb (PSA) 3'-UTRs contain sequences in common. The greatest similarity between these two 3'-UTRs is a 92-nucleotide segment with 66% identity. We found, using a beta -galactosidase reporter gene, that neither this 92-nucleotide 3'-UTR segment nor the downstream IR between the tandem MSPs or PSAs contributes directly to the regulation of these two RNA species. Therefore, we generated systematic deletions of other segments of the two 3'-UTRs. We discovered that the regions immediately flanking this 92-nucleotide segment are involved in regulating the levels of both the MSPS and PSA mRNAs through similar, but non-identical, mechanisms. These mechanisms have features in common with a recently proposed model for the regulation of the Trypanosoma brucei genes for EP and GPEET, the most abundant proteins on the surface of the insect form of African trypanosomes (29-32).

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Parasites-- A strain of L. chagasi (MHOM/BF/00/1669) was originally isolated from a Brazilian patient with visceral leishmaniasis. Virulent parasites were maintained in golden hamsters, and amastigotes were isolated from infected hamster spleens. Amastigotes convert into promastigotes when cultivated in vitro at 26 °C in hemoflagellate-modified minimal essential medium supplemented with 10% heat-inactivated fetal bovine serum and 5.6 µg hemin/ml at pH 7.4 (33). For most experiments, promastigote cultures were seeded at 1 × 106 parasites/ml, and stationary phase was achieved in 7-8 days. Logarithmic and stationary phase were defined according to concentration and morphologic changes as described (34). Promastigote cultures used for stable transfections were used within 3 weeks of isolation from a hamster. The medium used for selection and maintenance of stably transfected promastigotes contained 50 µg of G418/ml (Invitrogen). All frozen stocks of promastigotes were prepared within two passages in liquid media after clonal isolation to avoid the effects of attenuation due to long term serial passaging in culture.

For subsequent analyses, aliquots of ~1.5 × 108 promastigotes were removed either daily or during logarithmic (day 3) and stationary (day 7) phases of growth. Parasites were washed in sterile Dulbecco's phosphate-buffered saline (1×) (Invitrogen) 3 times by centrifugation for 5 min at 4000 × g, then resuspended in 1.4 ml of phosphate-buffered saline (1×). The final cell pellet was frozen in a dry ice/ethanol bath and stored at -70 °C. Cells for northern, Southern, and enzymatic analyses were harvested separately from the same tissue culture flask for each stage of growth. Cell densities were measured to confirm the stage of growth because the duration of the lag phase and the growth rates vary slightly from experiment to experiment. Data collected from each cell line represent multiple transfections with the same plasmid to minimize variability due to the particular condition of the parasites isolated from different hamsters.

Plasmid Constructions-- The Leishmania expression vector, pXbeta GAL2, was kindly provided by Stephen Beverley (36). In earlier studies, plasmids were constructed in which the corresponding 3'-UTRs and IR regions of the three MSP gene classes, i.e. MSPS, MSPL, and MSPC, were cloned at the XbaI site downstream of the beta GAL-coding region in pXbeta GAL2 (36, 37). A fragment containing the 3'-UTR and IR of an L. chagasi PSA gene, called PSAA, was isolated by NotI digestion of a genomic DNA phage clone and ligated into a NotI site downstream of the beta GAL gene in pXbeta GAL2. Recombinant constructs containing mutations in these 3'-UTRs were initially constructed in pBluescript, after which the mutant 3'-UTRs were gel-purified and cloned downstream of beta GAL in pXbeta GAL2. Nucleotide sequences and orientations were confirmed by DNA sequencing.

The plasmids used in the 3'-UTR and IR swapping experiments (Fig. 1) and the 3'-UTR deletion experiments (Figs. 2, 4, 6, and 8) were derived from the above-described plasmids containing the full PSAA and MSPL 3'-UTR and IRs using spliced overlap extension (SOE) PCR (38) followed by appropriate restriction enzyme digestion and ligation. The SOE PCR strategy facilitated the specific deletion of nucleotides from large plasmids in which removal by restriction enzyme digestion was limited. The primers used for the deletion constructs are shown in Figs. 3 and 7. Some primers were designed to create a unique AvrII site (5'-CCTAGG) at the site of deletion to facilitate the insertion of non-leishmanial DNA sequences.

Replacement constructs were prepared in which non-leishmanial linker DNA sequence and/or wild type sequence was inserted at the location of the deletion in the deletion constructs. The inserted non-leishmanial DNA sequence was selected to conserve length and GC nucleotide content. The template for these PCR reactions was the pBluescript polylinker region. PCR products were digested with AvrII and ligated into this unique restriction site in the pXbeta GAL2 construct at the deletion. Constructs ADelta 3A and ADelta 3B (Fig. 4) were generated from ADelta 3 by constructing a fusion between part of the wild type region 3 sequence and the non-leishmanial sequence (pBluescript). The resulting recombinant fragment was then ligated into ADelta 3 at the unique AvrII site at the deletion. Deletions in the 3'-UTR of MSPS (Figs. 7 and 8) were made by the same SOE PCR procedures as those described above for the deletions in the 3'-UTR of PSAA.

Generation and Activity Assays of Stable Tranfectants-- L. chagasi promastigotes were stably transfected and cloned according to the published protocol (33), a procedure that took an average of 2-3 months to obtain each stably transfected clone. Transfected cells were harvested, and cell pellets were resuspended in 100 ml of lysis buffer (100 mM KH2PO4, pH 7.8, 0.33% Triton X-100), lysed by three freeze-thaw cycles, sonicated for 5 min, and centrifuged for 5 min at 10,000 × g. The supernatant was assayed for protein concentration (bicinchoninic acid reagent and assay, Pierce) and beta GAL activity (using Galacton-Star chemiluminescent substrate, CLONTECH, Palo Alto, CA). Fluorescence was measured in triplicate in a Monolight 2010 luminometerTM (Analytical Luminescence Laboratory, San Diego, CA).

Data from each experimental clone were normalized to a control transfectant containing the parent plasmid, pXbeta GAL2, to eliminate variability due to differences in isolates and growth conditions. Multiple clones from each transfection condition were used in assays to establish consistency among different clones.

Calculations and Statistics-- beta GAL activities for each transfectant were recorded as the average of three readings at a 1:10 dilution of cell lysate as prepared above. Total protein concentrations were recorded in µg/µl. Relative fluorescence units (RFU) were calculated as (beta GAL activity/µl of cell lysate assayed)/1000. RFU/µg of total protein was then calculated as (RFU/µl of supernatant)/(protein concentration in µg/µl).

RFU/µg of protein for each transfectant was normalized to the RFU for the control transfectant containing the parent plasmid. The ratios of normalized stationary phase activity to normalized logarithmic phase activity were calculated for each transfectant. Figures contain the means ± S.D. of these normalized RFUs and stationary/log (S/L) ratios. The latter are referred to as the mean normalized S/L beta GAL values. Statistical comparisons were done using Student's t test with SigmaStat® software (version 2.03, SPSS Inc.).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The 3'-UTR of PSAA (3'-UTRPSAA), but not Its Downstream IR, Influences Expression of a beta GAL Reporter Gene-- We previously cloned the 3'-UTRs and downstream IRs of the three L. chagasi MSP gene classes, MSPS, MSPL, and MSPC, and of a specific L. chagasi PSA gene, PSAA, downstream of beta GAL in the Leishmania expression plasmid, pXbeta GAL2 (36), and examined their effects on beta GAL expression (20, 37). Constructs of the different plasmids were transfected into virulent L. chagasi promastigotes, and cloned transfectants were grown from logarithmic to stationary phase in vitro. Samples were removed at different times of growth for determination of beta GAL enzyme activities and beta GAL RNA levels. These experiments showed that expression of beta GAL mRNA and activity closely paralleled expression of the MSPS, MSPL, or PSA whose 3'-UTR + IR was cloned downstream of beta GAL. For example, when the 3'-UTR + IR of MSPS or PSAA was after beta GAL, the beta GAL activities and RNA levels were low in logarithmic phase and steadily increased to 20-30-fold higher as the recombinant promastigotes grew to stationary phase (20). In contrast, when the 3'-UTR + IR of MSPL was inserted after beta GAL, beta GAL expression remained at a low basal level throughout promastigote growth even though the wild type MSPL RNA is expressed more highly in logarithmic than in stationary growth (20). Southern blots and nuclear run-on assays were used to show that in these cloned stable transfectants the beta GAL gene copy number does not change during promastigote growth in culture under constant drug selection and that the pX vector sequences are constitutively transcribed (shown in Refs. 20 and 39).

To determine whether either the 3'-UTR or IR or both are the sequences responsible for the growth-associated regulation of PSAA, we first "swapped" the 3'-UTRs and IRs of PSAA and MSPL, as shown in Fig. 1. Plasmid constructs were made in which the beta GAL-coding region in plasmid pXbeta GAL2 was followed either by 3'-UTRPSAA + IRMSPL or by 3'-UTRMSPL + IRPSAA (see "Experimental Procedures"). These linearized constructs were stably transfected into virulent L. chagasi promastigotes. The beta GAL activities and RNA levels in these cloned cells in logarithmic (3 days of growth) versus stationary phase (7 days of growth) were compared with the corresponding constructs containing beta GAL followed by the complete 3'-UTR + IR of either PSAA or MSPL (Fig. 1).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 1.   3'-UTR and IR swapping experiments showing that cis-regulatory elements reside in the 3'-UTR of PSAA, not the IR. Promastigotes were stably transfected with derivatives of pXbeta GAL2 in which the sequences cloned immediately downstream of beta GAL were as illustrated schematically. Large open rectangles represent the beta GAL-coding region. Large solid rectangles are 3'-UTR sequences, and thin solid rectangles are IR sequences. beta GAL activities (RFU/µg of protein) in logarithmic (L) and stationary (S) phase cells were measured and normalized to the activity of a transfectant containing the parent plasmid in the same growth phase (as detailed under "Experimental Procedures"). The ratios of these normalized beta GAL activities in stationary versus logarithmic phase transfectants (S/L) were calculated and are shown for each transfectant (left column of numbers). RNAs were isolated from the same transfectants and probed in Northern blots with the beta GAL-coding sequence to determine the S/L ratio of steady state RNA levels (right column of numbers). Signals in the Northern blots were quantitated by instant image analyses.

The ratio of beta GAL activity in stationary versus logarithmic cells (S/L in Fig. 1) was about 30 when the 3'-UTR + IR of PSAA was after beta GAL. The ratio was unchanged when beta GAL was followed by 3'-UTRPSAA + IRMSPL. In each case, the 30-fold increase in beta GAL activity in stationary cells compared with logarithmic cells was accompanied by a corresponding increase in the beta GAL RNA steady state level, as measured by instant imager analyses of Northern blots (summarized in the right-hand column of Fig. 1) and as demonstrated previously for PSAA (20). In contrast, when beta GAL was followed either by 3'-UTRMSPL + IRMSPL or by 3'-UTRMSPL + IRPSAA, the S/L ratio of both beta GAL activity and beta GAL RNA was less than one. Thus, the 3'-UTR sequence appears to account in large part for the increased expression of PSAA and the lack of change in MSPL RNA during the logarithmic-to-stationary transition. In contrast, the downstream IR sequences do not appear to play a role. A further conclusion from both these results and earlier results (20, 37) is that beta GAL activity reflects the steady state level of beta GAL RNA in these constructs containing downstream PSAA and MSPS sequences

Deletion of a 92-Nucleotide Segment of Sequence Similarity in the 3'-UTRs of PSAA and MSPL Does Not Affect Gene Regulation-- Previously we showed that the steady state levels of both PSAA and MSPS RNAs increase in parallel as virulent promastigotes grow from logarithmic to stationary phase (20). We also showed that, similar to the 3'-UTRPSAA results above, the increase in the MSPS RNA abundance is regulated primarily by elements in the 3'-UTRMSPS (37). We therefore inspected the 1.3-kb 3'-UTRPSAA and the 1.0-kb 3'-UTRMSPL for shared sequence elements (Fig. 2A). The region of greatest similarity is a 92-nucleotide segment of 66% identity called the overlap or olp region. Two other small (<10 bp) regions of limited similarity are located upstream of olp. To see if this similar 92-nucleotide olp segment in each of the two 3'-UTRs contributes to the parallel regulation of their RNAs, the 92 nucleotides were deleted from each 3'-UTR by the SOE PCR technique (see "Experimental Procedures"), and the resultant Delta olp 3'-UTR + IR was cloned immediately downstream of beta GAL in pXbeta GAL2 for subsequent stable transfections and beta GAL activity measurements.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 2.   Alignment of the segments with the most sequence similarity (olp) in the 3'-UTRPSAA and 3'-UTRMSPS and the beta GAL activities of promastigotes stably transfected with constructs in which olp is deleted. A, in the two schematic diagrams representing PSAA and MSPS, the large open rectangles depict the coding regions, and the thin gray rectangles show the 3'-UTRs of PSAA and MSPS. The smaller rectangles within the two 3'-UTRs indicate the segments of greatest 3'-UTR similarity. The largest region of similarity is 92 nucleotides with 66% identity. These segments are located 416 bp (PSAA) and 213 bp (MSPS) upstream of the polyadenylation sites. Nucleotide numbers indicate nucleotide positions in full-length PSAA and MSPS cDNAs. B, the results from beta GAL assays are shown for the indicated transfectants as described in the text. The letter A indicates the presence of an AvrII site at the location of the olp deletion. N is the number of independent experiments in which data were obtained for each transfected cell line. For each experiment, the RFU/µg of protein for each transfectant were normalized to the values for the transfectant containing the parent plasmid at the same phase of growth (which was included in each experiment). The mean normalized beta GAL S/L ratio ±S.D. was calculated as described under "Experimental Procedures." The S.D. was calculated using SigmaStat® statistical software.

Fig. 2B shows that deletion of this olp region from these two 3'-UTRs had little if any effect on the regulatory role of either 3'-UTR. The S/L beta GAL activity ratio was about 30 ± 3.5 when the 3'-UTRPSAA was present and about 46 ± 16 when the 3'-UTRPSAADelta olp was present, yielding a statistically insignificant p value of 0.155. Likewise, the S/L beta GAL ratio was about 63 ± 9 and 59 ± 15 in the presence of the 3'-UTRMSPS and 3'-UTRMSPSDelta olp, respectively. Thus, by this targeted deletion analysis it appears the 3'-UTRs do not need the olp segment to up-regulate their RNA levels during growth to stationary phase. This conclusion prompted us to conduct a more systematic deletion analysis of the two 3'-UTRs.

Specific Segments of the 3'-UTRPSAA Are Involved in Gene Regulation-- Because deletion of the olp segment did not abrogate logarithmic-stationary gene regulation, we used RNA secondary structure prediction programs to examine the 3'-UTRs of PSAA and MSPS for potential secondary structures that might provide clues about their involvement in regulation. Both 3'-UTRs are about 90% G+C+U, so unfortunately, when both G-C and G-U base pairing are allowed, the number, sizes, and complexities of possible hairpin loops in these 3'-UTRs of 1.0 and 1.3 kb are immense. Thus, these secondary structure analyses were not informative, even when smaller regions of the 3'-UTRs were examined (not shown). Therefore, the two 3'-UTRs were tested further for regulatory sequence elements by deleting ~200-bp segments across the entire 3'-UTR using the SOE PCR technique. In the case of the 3'-UTRPSAA, five adjacent segments were individually deleted (Fig. 3) and the constructs, called ADelta 1-ADelta 5, were cloned into pXbeta GAL2 for stable transfection into virulent promastigotes and subsequent analyses (Fig. 4). The right-hand boundary of the deletion in construct ADelta 5 was designed to occur 13 nucleotides upstream of the polyadenylation site to preserve this site. Point mutations were introduced into SOE PCR primers so that a unique restriction site, AvrII, would be present in recombinant constructs at the site of the deletion. To determine whether changes in beta GAL expression were merely due to changes in spacing generated by deletions, the AvrII sites were used to insert non-leishmanial DNA (from pBluescript) of the same length and GC nucleotide content as the 200-bp deletion. This generated another series of recombinant constructs called ADelta 1link-ADelta 5link. The plasmid deletion constructs and their corresponding linker constructs were stably transfected into promastigotes, and the beta GAL activities in logarithmic and stationary phase cells were analyzed. In every case the beta GAL activities derived from a given 200-bp deletion construct and its corresponding "link(er)" construct were found to be equivalent within experimental error (not shown). Thus, Fig. 4 shows the data for only the deletion constructs.


View larger version (74K):
[in this window]
[in a new window]
 
Fig. 3.   Sequences and locations of the SOE primers used to create deletions in the 3'-UTRPSAA. Both strands of the 3'-UTR are shown. The TGA stop codon is boxed. The vertical arrow points to the polyadenylation site. SOE PCR primers are shown with arrows pointing in the 3' direction above or below their corresponding sequences, which are shaded gray. The 5' tails required for the SOE PCR amplification are shown as angled lines with solid black circles extending off the arrow.


View larger version (31K):
[in this window]
[in a new window]
 
Fig. 4.   The 3'-UTRPSAA contains a negative element in segment 1 and positive regulatory elements in segments 3 and 4. The plasmids stably transfected into promastigotes are depicted by schematic diagrams. Large open rectangles indicate the beta GAL-coding region. Other rectangles of different shades of gray represent different segments of the 3'-UTRPSAA. Lines after the rectangles depict the IR sequence. The segments are numbered above the corresponding rectangle. The letter A indicates an AvrII site. For each construct, data were obtained from a minimum of three independent experiments with each transfected cell line. The mean normalized beta GAL S/L ratio was calculated as described under "Experimental Procedures" and is represented by the mean value ±S.D. The mean normalized beta GAL S/L values for each transfectant was recorded and compared with the mean normalized S/L beta GAL value of the transfectant containing the wild type 3'-UTR. These calculations are recorded as fold differences versus wild type and were performed using the Student's t test to obtain a p value. Increases in the S/L beta GAL ratio are shown by arrows pointing up; decreases are shown by arrows pointing down. For example, there is a 2.7-fold (or 81.3/30.5) increase in the mean normalized S/L ratio in the transfectant containing ADelta 1 compared with wild type.

Deletion ADelta 1 caused a 2.7-fold increase in the S/L beta GAL ratio compared with the wild type (wt) 3'-UTRPSAA, suggesting there may be a negative control element in this segment. Other deletions had no effect (ADelta 2) or caused a decrease (ADelta 3, ADelta 4, ADelta 5) in the S/L ratio. Deletions ADelta 3 and ADelta 4 exhibited the largest effects, i.e. decreases of 11- and 15-fold in the S/L ratio, respectively. Interestingly, these deleted segments flank olp, whose deletion had no effect (compare Figs. 2 and 4). Thus, sequences deleted in the ADelta 3 and ADelta 4 constructs possess a positive control element(s) that increases beta GAL activity in stationary cells.

To further map putative positive regulatory elements, plasmid constructs ADelta 3A and ADelta 3B were generated to examine the individual effects of each half of segment 3. In each of these constructs, a non-leishmanial sequence was introduced to preserve the position of the wild type sequence within the 3'-UTR. To our surprise, the presence of either half of segment 3 did not restore wild type beta GAL activity in stationary phase (Fig. 4). A similar half-deletion of segment 4 was not constructed.

The locations of the two nucleotide replacements in construct ADelta 3 that were used to create the AvrII site (5' CCTAGG) at the site of the ADelta 3 deletion are shown in Fig. 5. Insertion of a 200-bp linker sequence into this site did not significantly change the beta GAL S/L ratio from that shown for ADelta 3 in Fig. 4 (not shown). Surprisingly, however, re-insertion of the wild type segment 3 sequence into the AvrII site also did not restore the wild type S/L beta GAL ratio (Fig. 6, compare ADelta 3 and ADelta 3wt). Because the only difference between the ADelta 3wt and PSAA 3'-UTR constructs is the AvrII site, we tested whether the AvrII site itself might be responsible for this unexpected result. Three additional constructs were prepared (Fig. 6). To prepare construct ADelta 3wt5', the SOE PCR primers were designed to eliminate the AvrII site on the 5' side of segment 3 and retain it on the 3' side. In construct ADelta 3wt3', the AvrII site was eliminated on the 3' side of segment 3 and retained on the 5' side. Finally, in construct ADelta 3Avr(-), segment 3 was deleted from the 3'-UTRPSAA by SOE PCR without generation of an additional AvrII site. In the resulting stable transfectants, the wild type S/L beta GAL ratio was restored in construct ADelta 3wt3' but not in construct ADelta 3wt5' (Fig. 6). Thus, replacement of two nucleotides to generate an AvrII site at the segment 3-olp boundary of ADelta 3wt5' (Fig. 5) is sufficient to cause loss of logarithmic-stationary regulation. However, when segment 3 was deleted without the concomitant insertion of an AvrII site in construct ADelta 3Avr(-),the logarithmic-stationary regulation of beta GAL was abrogated even more completely than the ADelta 3 construct (20.6-fold decrease versus 11.3-fold decrease). Thus, the presence of the non-mutated sequence at the 3'-end of segment 3 alone is not sufficient to confer wild type regulation.


View larger version (14K):
[in this window]
[in a new window]
 
Fig. 5.   Comparison of the boundaries between segment 3 and olp in the 3'-UTRPSAA and 3'-UTRMSPS. Vertical lines between nucleotides in the olp (OLP) region indicate identical nucleotides. Diagonal lines indicate five additional nucleotides of identity detected after the experiments were conducted. The nucleotides mutated to generate an AvrII site (5'-CCTAGG) in constructs ADelta 3 and SDelta 3 are shown.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 6.   Additional characterizations of the effect of deletions of segment 3 and segment 4 in the 3'-UTRPSAA. Plasmids are depicted by schematic diagrams as described in the legend for Fig. 4. The relative positions of AvrII (A) sites are shown. The mean normalized beta GAL S/L ratio was calculated as described in the legend for Fig. 4 and under "Experimental Procedures." For example, there is an 11.3-fold (or 30.5/2.70) decrease in the mean normalized S/L ratio in the ADelta 3 transfectants compared with wild type. The data shown in Fig. 4 for the wild type construct and constructs ADelta 3 and ADelta olp are also shown here for the sake of comparison.

Because an AvrII site had also been engineered at the deletion site in the ADelta 4 construct (Figs. 4 and 6), the segment 4 wild type sequence was also reinserted into this AvrII site to generate construct ADelta 4wt. In this case and in contrast to construct ADelta 3wt, the wild type S/L beta GAL ratio was restored in ADelta 4wt (Fig. 6). Thus, the presence of the AvrII site does not appear to alter regulation of beta GAL expression in the ADelta 4 constructs as it does with the ADelta 3 construct. Similarly, in experiments not shown, transfectants containing plasmid constructs in which only each end of segment 4 is mutated to an AvrII site have wild type S/L beta GAL ratios.

Specific Segments of the 3'-UTRMSPS Are Also Involved in Gene Regulation-- A deletion analysis of the 1.0-kb 3'-UTRMSPS was also undertaken similar to the 3'-UTRPSAA analysis (Figs. 7 and 8). Four deletion constructs with deleted segments replaced by a single AvrII site, called SDelta 1-SDelta 4, were cloned into pXbeta GAL2 and stably transfected into virulent promastigotes. Also similar to the PSAA analysis, in each case non-leishmanial DNA (from pBluescript) of the same size and GC content as the deleted segment was cloned into the AvrII site, producing a corresponding set of constructs called SDelta 1link-SDelta 4link. As was found with the 3'-UTRPSAA, the S/L beta GAL ratio of a given deletion construct and its corresponding linker construct were found to be the same within experimental error, so only the deletion data are shown (Fig. 8).


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 7.   Sequences and locations of the SOE primers used to create deletions in the 3'-UTRMSPS. The symbols are the same as indicated in the legend for Fig. 3.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 8.   Segments 3 and 4 of the 3'-UTRMSPS contain positive regulatory elements. Plasmids are depicted by schematic diagrams as described in the legend for Fig. 4. The mean normalized beta GAL S/L ratio was calculated as described in the legend for Fig. 4 and under "Experimental Procedures." For example, there is a 7.5-fold (or 62.5/8.37) decrease in the mean normalized S/L ratio in the SDelta 3 transfectants compared with wild type.

Deletion SDelta 1 had no effect on the beta GAL S/L ratio compared with wild type, and SDelta 2 resulted in only about a 2-fold change. In contrast, SDelta 3 and SDelta 4 caused 7.5- and 3.5-fold decreases in the S/L ratio, respectively. Thus, similar to the 3'-UTRPSAA data, deletions of the segments flanking the olp region exerted the largest effects, and in both cases, the deletions caused a decrease of the beta GAL S/L ratio. Constructs SDelta 3A and SDelta 3B were also generated to examine the effects of each half of segment 3 (Fig. 8). Similar to the findings with ADelta 3A and ADelta 3B (Fig. 4), the presence of either half of segment 3 of the 3'-UTRMSPS did not restore the wild type S/L ratio. Thus, the positive regulatory element(s) extends across both halves of segment 3 of the 3'-UTRMSPS as it does in segment 3 of the 3'-UTRPSAA.

Because of the effects of the engineered AvrII site in some of the 3'-UTRPSAA constructs, the wild type segment 3 sequence was reinserted at the AvrII site of construct SDelta 3 to generate construct SDelta 3wt. Fig. 5 shows the three-nucleotide replacements that were generated during SOE PCR to create this AvrII site. In contrast to ADelta 3wt (Figs. 4 and 6), insertion of wild type segment 3 sequence into the AvrII site of SDelta 3 restored the wild type S/L beta GAL ratio (SDelta 3wt in Fig. 8). A similar restoration of wild type activity was obtained when the wild type segment 4 sequence was replaced into the AvrII site of SDelta 4 (not shown). Thus, the nucleotide replacements used to create the AvrII site in these SDelta constructs do not affect expression of the upstream beta GAL gene.

Insertion of Region 3 from the 3'-UTRPSAA Did Not Restore Regulation in Construct SDelta 3-- Because deletions of the segments flanking the olp region in both 3'-UTRMSPS and 3'-UTRPSAA had similar effects, we tested whether these segments in one 3'-UTR could be replaced with the corresponding segments of the other 3'-UTR and still retain the regulation. Therefore, PSAA segment 3 was inserted into the AvrII site of construct SDelta 3 to generate construct SDelta 3-Awt3 (bottom of Fig. 8). In contrast to SDelta 3wt, the wild type S/L beta GAL ratio of the 3'-UTRMSPS was not restored in SDelta 3-Awt3. Instead, the S/L ratio of the original SDelta 3 dropped even further, i.e. from 7.5- to 22.2-fold. A similar result was obtained when PSAA segment 4 was inserted into construct SDelta 4, i.e. the wild type S/L beta GAL ratio dropped still further instead of being restored (data not shown). Therefore, in these two examples the regulatory region of one 3'-UTR could not replace the correspondingly positioned regulatory region of the other 3'-UTR, suggesting that these regulatory regions function only within the context of their own 3'-UTRs.

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The purpose of the current work was to map sequences in the 3'-UTRs of two tandemly repeated gene classes of L. chagasi whose mRNAs are expressed at similar times in the growth cycle of the parasite. We hypothesized that similar molecular features would account for their similar patterns of expression. Our data revealed that the mechanisms regulating levels of MSPS and GP46A RNAs are likely to be complex, involving at least several regions of their 3'-UTRs. Furthermore, our data suggest that different features of each of these 3'-UTR sequences regulate gene expression.

Many differentially expressed trypanosomatid genes are regulated post-transcriptionally by molecular mechanisms involving their 3'-UTRs (21-28, 40-42). The most extensively studied group of post-transcriptionally regulated genes in trypanosomatids is the T. brucei gene family encoding the related acidic repetitive proteins, EP and GPEET (previously called procyclic acidic repetitive protein or PARP (43)), found exclusively on the surface of the procyclic (insect) form of T. brucei (29, 30). The coding regions of the EPs and GPEETs in the T. brucei genome are similar, but their short 3'-UTRs (300 bp) share only a conserved 26-mer sequence. The 100-fold higher steady state level of the EP and GPEET mRNAs in the procyclic form than in the bloodstream form is controlled mainly by elements in their 3'-UTRs (30, 44, 45). Deletion analysis of the EP1 3'-UTR (30, 32) and characterization of its secondary structure by RNase digestion and lead hydrolysis (31) indicate that this 3'-UTR consists of three domains, I, II, and III. The 5' and 3' domains I and III, respectively, form independent stem-loop structures in the RNA, whereas the central domain II contains the conserved 26-mer as a single-strand. Domains I and III both have positive regulatory elements, and it has been proposed that in procyclic trypanosomes one or more factors bind to these positive elements in the flanking stem-loops, shielding domain II from endonuclease degradation. In bloodstream trypanosomes, which presumably lack these positive regulators, the single-stranded domain II is exposed to endonuclease activity and quickly degraded (29, 31).

Similar to T. brucei EP and GPEET, Leishmania PSA and MSP are the major surface glycoproteins on the insect form of parasite, and these Leishmania and T. brucei genes are post-transcriptionally regulated in a parallel manner via their dissimilar 3'-UTR sequences. The extent to which the patterns of cis-acting regulatory elements in the 3'-UTRs of their mRNAs resemble each other is intriguing. Similar to the EPs and GPEETs, PSAA and MSPS are regulated in a parallel fashion by their 3'-UTRs, yet these 3'-UTRs contain little sequence similarity. Likewise, similar to domains I and III of the EP1 3'-UTR, segments 3 and 4 of the PSAA and MSPS3'-UTRs contain positive regulatory elements that flank a conserved region (domain II in the EPs and olp in PSAA and MSPS). In the 3'-UTRPSAA, deletions of segments 3 and 4 result in an 11- and 15-fold loss, respectively, in PSAA up-expression in stationary phase (Fig. 4). In the 3'-UTRMSPS, deletions of segments 3 and 4 cause a 7.5- and 3.5-fold drop, respectively, in MSPS up-expression in stationary phase (Fig. 8). In both of these Leishmania genes the positive regulatory element(s) in segment 3 could not be further localized by deleting just the 5' or the 3' half of segment 3. Similarly, the positive regulatory element(s) in domains I and III of the EP1 3'-UTR extend across the stem-loop in most of the domain (30-32). The PSAA and MSPS data also suggest that the regulatory elements in segments 3 and 4 are both necessary, but neither is sufficient to confer full up-regulation of gene expression, again similar to domains I and III of EP1. It is not known whether possible hairpin loops in segments 3 and 4 of PSAA and MSPS play the same roles as the hairpin loops in domains I and III of the EP13'-UTR (31). The 200-nucleotide sequences of segments 3 and 4 have potential hairpin loops, as detected by RNA secondary structure prediction programs (not shown), but these sequences are too long for the predictions to be reliable. RNase digestion and lead hydrolysis experiments, similar to those conducted on the EP1 3'-UTR (31), will be necessary to clarify this question.

Unexpectedly, when the sequence of segment 3 was reintroduced into the engineered AvrII site in the ADelta 3 deletion construct, wild type activity was not restored (Fig. 6). However, when the sequence at the 3' boundary but not at the 5' boundary of segment 3 was restored to wild type (i.e. without the AvrII site), activity was restored to wild type level. Thus, the wild type context at the 3' end of segment 3 is necessary for regulation of PSAA stationary phase expression. However, it is not a sufficient regulatory factor, since wild type regulation was not achieved by the presence of the wild type 3' end of segment 3 alone, as demonstrated by experiments with transfectants containing the ADelta Avr(-) deletion construct (Fig. 6). This ADelta Avr(-) construct shows that the two altered bases at the 3' end of segment 3 do not substitute for the entire segment 3. Furthermore, the positive effect of segment 3 and its wild type 3' sequence (Figs. 4-6) was active only when the olp sequence was present. When the olp sequence was deleted, ADelta olp, replacement of the two bases to generate the AvrII site at the 3' end of segment 3 (Fig. 5) did not have the negative effect on regulation that is demonstrated by ADelta 3wt and ADelta 3wt5' (Fig. 6). These data are consistent with a model in which positive regulation by segment 3 results from shielding a negative element in the olp segment, such as a degradation signal. When the degradation signal is absent, as in the ADelta olp deletion construct, the protective effect of segment 3 is unnecessary, and wild type regulation is achieved. This is analogous to the involvement of domains I and II in the regulation of EP/GPEET expression.

When segment 4 of 3'-UTRPSAA is deleted, there is a 15-fold loss of regulation that can be restored by reintroduction of wild type sequence into the engineered AvrII site (Fig. 6), again similar in this case to the involvement of domains II and III in the regulation of EP/GPEET expression. Thus, segments 3 and 4 are necessary but not sufficient alone for regulation of PSAA gene expression. To determine whether these segments interact, a construct in which both segments are deleted will be necessary.

In summary, the regulatory effects of the 3'-UTRPSSA and 3'-UTRMSPS are clearly complex and multifaceted. Our data are consistent with a model in which segment 1 of the 3'-UTRPSAA contains a modest negative regulatory element, resulting in a 2.7-fold negative regulatory effect. Segments 3 and 4 each contain positive regulatory elements that appear to shield the olp region. Similarly, the 3'-UTRMSPS contains positive regulatory elements in segments 3 and 4 that flank the olp region, although there does not appear to be a weak negative regulator in segment 1 as there is in the 3'-UTRPSAA. Nucleotides at the boundary between segment 3 and olp appear to be critical for PSAA regulation, but we have no evidence for their involvement in MSPS regulation (Figs. 5, 6, and 8). The AvrII site in the 3'-UTRPSAA constructs was generated by two replacement mutations separated by a single base pair, both of which are in segment 3. The AvrII site in the 3'-UTRMSPS was generated by three replacements, one of which is in segment 3 and two of which are adjacent to each other three base pairs downstream in the olp sequence. Five additional adjacent nucleotides in segment 3 are shared between the 3'-UTRPSAA and 3'-UTRMSPS, as indicated by the diagonal lines in Fig. 5. All three replacements used to generate the AvrII site in the 3'-UTRMSPS disrupt identical nucleotides in the two 3'-UTRs, yet there was only an effect on the regulation of PSAA3'-UTR constructs. It will be worthwhile to determine whether these five nucleotides are important in the regulation conferred by the 3'-UTRPSAA but not 3'-UTRMSPS.

The similar features in the regulation of these Leishmania genes and those of the T. brucei EP/GPEETs support the possibility that there are common themes to the molecular mechanisms determining post-transcriptional regulation of trypanosomatid gene expression through sequences in their 3'-UTRs. Further elucidation of these regulatory mechanisms will require an even more detailed dissection of the 3'-UTR sequences and the potential proteins with which they interact than has been undertaken to date.

    FOOTNOTES

* This work was supported in part by National Institutes of Health Grants AI32135 and AI43050 and a Veterans Affairs Merit Review grant.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Present address: Dept. of Veterinary Pathology, Iowa State University, Ames, IA 50011.

§§ To whom correspondence should be addressed. Tel.: 319-335-7934; Fax: 319-353-4204; E-mail: john-donelson@uiowa.edu.

Published, JBC Papers in Press, February 20, 2002, DOI 10.1074/jbc.M200174200

    ABBREVIATIONS

The abbreviations used are: MSP, major surface protease of 63 kDa; PSA, parasite-specific antigen of 46 kDa; UTR, untranslated region; IR, intergenic region from the poly(A) addition site of one gene to the ATG start codon of the downstream gene; beta GAL, beta -galactosidase; SOE, spliced overlap extension; RFU, relative fluorescence units; olp, overlap region; kb, kilobase(s); S/L ratio, stationary/log ratio; bp, base pair(s); wt, wild type; EP, dipeptide repeat protein; GPEET, pentapeptide repeat protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Clayton, C., Adams, M., Almeida, R., Baltz, T., Barrett, M., Bastien, P., Belli, S., Beverley, S., Biteau, N., Blackwell, J., Blaineau, C., Boshart, M., Bringaud, F., Cross, G., Cruz, A., Degrave, W., Donelson, J., El-, Sayed, N., Fu, G., Ersfeld, K., Gibson, W., Gull, K., Ivens, A., Kelly, J., Lawson, D., Lebowitz, J., Majiwa, P., Matthews, K., Melville, S., Merlin, G., Michels, P., Myer, P., Norrish, A., Opperdoes, F., Papadopoulou, B., Parsons, M., Seebeck, T., Smith, D., Stuart, K., Turner, M., Ullu, E., and Vanhamme, L. (1998) Mol. Biochem. Parasitol. 97, 221-224[CrossRef][Medline] [Order article via Infotrieve]
2. McMahon-Pratt, D., Rodriguez, D., Rodriguez, J. R., Zhang, Y., Manson, K., Bergman, C., Rivas, L., Rodriguez, J. F., Lohman, K. L., Ruddle, N. H., and Esteban, M. (1993) Infect. Immun. 61, 3351-3359[Abstract/Free Full Text]
3. Noormohammadi, A. H., Hochrein, H., Curtis, J. M., Balwin, T. M., and Handman, E. (2001) Vaccine 19, 4043-4053[CrossRef][Medline] [Order article via Infotrieve]
4. Handman, E., Noormohammadi, A. H., Curtis, J. M., Baldwin, T., and Sjolander, A. (2000) Vaccine 18, 3011-3017[CrossRef][Medline] [Order article via Infotrieve]
5. Frankenburg, S., Axelrod, O., Kutner, S., Greenblatt, C. L., Klaus, S. N., Pirak, E. A., McMaster, W. R., and Lowell, G. H. (1996) Vaccine 14, 923-929[CrossRef][Medline] [Order article via Infotrieve]
6. Olobo, J. O., Anjili, C. O., Gicheru, M. M., Mbati, P. A., Kariuki, T. M., Githure, J. I., Koech, D. K., and McMaster, W. R. (1995) Vet. Parasitol. 60, 199-212[CrossRef][Medline] [Order article via Infotrieve]
7. Brittingham, A., Morrison, C. J., McMaster, W. R., McGwire, B. S., Chang, K. P., and Mosser, D. M. (1995) J. Immunol. 155, 3102-3111[Abstract]
8. Russell, D. G., and Wilhelm, H. (1986) J. Immunol. 136, 2613-2626[Abstract]
9. Seay, M. B., Heard, P. L., and Chaudhuri, G. (1996) Infect. Immun. 64, 5129-5137[Abstract]
10. Wilson, M. E., Hardin, K. K., and Donelson, J. E. (1989) J. Immunol. 143, 678-684[Abstract]
11. Kweider, M., Lemesre, J. L., Santoro, F., Kusinerz, J. P., Sadigurzky, M., and Capron, A. (1989) Parasite Immunol. (Oxf.) 148, 197-209
12. Brittingham, A., Miller, M. A., Donelson, J. E., and Wilson, M. E. (2001) Mol. Biochem. Parasitol. 112, 51-59[CrossRef][Medline] [Order article via Infotrieve]
13. Roberts, S. C., Swihart, K. G., Agey, M. W., Ramamoorthy, R., Wilson, M. E., and Donelson, J. E. (1993) Mol. Biochem. Parasitol. 62, 157-172[CrossRef][Medline] [Order article via Infotrieve]
14. Ramamoorthy, R., Donelson, J. E., Paetz, K. E., Maybodi, M., Roberts, S. C., and Wilson, M. E. (1992) J. Biol. Chem. 267, 1888-1895[Abstract/Free Full Text]
15. Kahl, L. P., and MacMahon-Pratt, D. (1987) J. Immunol. 138, 1587-1595[Abstract]
16. Murray, P., Spithill, T., and Handman, E. (1989) J. Immunol. 143, 4221-4226[Abstract]
17. MaMohon-Pratt, D., Traub-Cseko, Y., Lohman, K. L., Rogers, D. D., and Beverley, S. M. (1992) Mol. Biochem. Parasitol. 50, 151-160[CrossRef][Medline] [Order article via Infotrieve]
18. Symons, F. M., Murray, P. J., Ji, H., Simpson, R. J., Osborn, A. H., Cappai, R., and Handman, E. (1994) Mol. Biochem. Parasitol. 67, 103-113[CrossRef][Medline] [Order article via Infotrieve]
19. Jimenez-Ruiz, A., Boceta, C., Bonay, P., Requuena, J. M., and Alonso, C. (1998) Eur. J. Biochem. 251, 389-397[Medline] [Order article via Infotrieve]
20. Beetham, J. K., Myung, K. S., McCoy, J. J., Wilson, M. E., and Donelson, J. E. (1997) J. Biol. Chem. 272, 17360-17366[Abstract/Free Full Text]
21. Graham, S. V. (1995) Parasitol. Today 11, 217-223[CrossRef][Medline] [Order article via Infotrieve]
22. Aly, R., Argaman, M., Halman, S., and Shapira, M. (1994) Nucleic Acids Res. 22, 2922-2929[Abstract/Free Full Text]
23. Nozaki, T., and Cross, G. A. M. (1995) Mol. Biochem. Parasitol. 75, 55-68[CrossRef][Medline] [Order article via Infotrieve]
24. Teixeira, S. M. R., Kirchhoff, L. V., and Donelson, J. E. (1995) J. Biol. Chem. 270, 22586-22594[Abstract/Free Full Text]
25. Coughlin, B. C., Teixeira, S. M. R., Kirchhoff, L. V., and Donelson, J. E. (2000) J. Biol. Chem. 275, 12051-12060[Abstract/Free Full Text]
26. Kelly, B. L., Nelson, T. N., and McMaster, W. R. (2001) Mol. Biochem. Parasitol 116, 101-104[CrossRef][Medline] [Order article via Infotrieve]
27. Charest, H., Zhang, W.-W., and Matlashewski, G. (1996) J. Biol. Chem. 271, 17081-17090[Abstract/Free Full Text]
28. Quijada, L., Soto, M., Alonso, C., and Requena, J. M. (2000) Mol. Biochem. Parasitol. 110, 79-91[CrossRef][Medline] [Order article via Infotrieve]
29. Roditi, I., Furger, A., Ruepp, S., Schürch, N., and Bütikofer, P. (1998) Mol. Biochem. Parasitol. 91, 117-130[CrossRef][Medline] [Order article via Infotrieve]
30. Hotz, H.-R., Biebinger, S., Flaspohler, J., and Clayton, C. (1998) Mol. Biochem. Parasitol. 91, 131-143[CrossRef][Medline] [Order article via Infotrieve]
31. Drozdz, M., and Clayton, C. (2000) RNA (N. Y.) 5, 1632-1644[Abstract]
32. Furger, A., Schürch, N., Kurath, U., and Roditi, I. (1997) Mol. Cell. Biol. 17, 4372-4380[Abstract]
33. LeBowitz, J. H. (1994) Methods Cell Biol. 45, 65-78[Medline] [Order article via Infotrieve]
34. Zarley, J. H., Britigan, B. E., and Wilson, M. E. (1991) J. Clin. Invest. 88, 1511-1521[Medline] [Order article via Infotrieve]
35. Deleted in proof
36. LeBowitz, J. H., Coburn, C. M., MacMahon-Pratt, D., and Beverley, S. M. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 9736-9740